Finally, we found that Ab-IPL-IL-17 effectively reduced clinical signs of experimental arthritis, decreased in vitro pro-inflammatory cytokine production by synovial fibroblast cells and neutralised elevated IL-17 levels in IBD patient serum following ex-vivo stimulation. Here, IL17A is linked to arthritic joint disease.